Prevention strategy definition

Prevention strategy means activities targeted to a spe- cific population or the larger community that are designed to be implemented before the onset of problems as a means to prevent substance abuse or its detrimental effects from occurring.
Sample 1Sample 2Sample 3

Examples of Prevention strategy in a sentence

  • Education, as one Prevention strategy highlighted in the Code, seeks to promote behavior in line with the values of clean sport and to help prevent Athletes and other Persons from doping.

  • Several programs which currently exist and for which EH&S has already established oversight have been incorporated into the overall campus Injury and Illness Prevention strategy.

  • Prevention strategy during pregnancy and early childhood may decrease the incidence rates.AimTo evaluate the effect of prenatal vitamin supplements on respiratory symptoms and morbidity in early infancy.Methods212 children and their mother were followed in prospective cohort study in 2001 to 2003 from pregnancy via delivery to the age of 6 months.

  • Focus Families workers are fully involved in the Prevention strategy and are also well established within the Early Help panels.

  • Prevention strategy centers on institutional punishment of policy violators, a strategy that some experts contend relies on the operationalizing of “scare tactics” (Haines, 1997, p.

  • It embraces Domestic Homicide Reviews and the Suicide Prevention strategy.

  • The Municipality fosters a zero tolerance to fraud and corruption anti-Fraud and Prevention strategy was approved and adopted by Council during November 2009 Council sitting.

  • The Municipality fosters a zero tolerance to fraud and corruption anti- Fraud and Prevention strategy was approved and adopted by Council during November 2009 Council sitting.

  • Prevention strategy focuses on directing institutional re- sources toward intervention and treatment.

  • Prevention strategy is non-adversarial and focuses on using the media to show students that their peers are “not as reckless as they think” (Kluger, 2001,p.

Related to Prevention strategy

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • spatial development framework means the Mhlontlo Municipal Spatial Development Framework prepared and adopted in terms of sections 20 and 21 of the Act and Chapter 2 of this By-Law;

  • municipal spatial development framework means a municipal spatial development framework adopted by the Municipality in terms of Chapter 5 of the Municipal Systems Act;

  • R2000 Strategy means an initiative by the Government of Kenya to improve the maintenance of the country’s Road Network by giving priority to maintenance through network approach, using appropriate technology, labour-based methods, local resources and increased usage of small-scale entrepreneurs.

  • Collaboration has the meaning set forth in Section 2.1.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Medical Affairs Activities means, with respect to any country or other jurisdiction in the Territory, the coordination of medical information requests and field based medical scientific liaisons with respect to Licensed Compounds or Licensed Products, including activities of medical scientific liaisons and the provision of medical information services with respect to a Licensed Compound or Licensed Product.

  • Medical cannabis means the same as that term is defined in Section 26-61a-102.

  • scientific research means any activity in the field of natural or applied science for the extension of knowledge;

  • Infill development means new construction on a vacant commercial lot currently held as open space.

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Clinical Data means the information concerning the safety or performance that is generated from the use of a device and that are sourced from the following:

  • Strategy means the account opened by a Strategy Provider to carry out a series of transactions for the purpose of Social Trading and which is available for Investors to copy and invest.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Soil scientist means an individual duly qualified in accordance with standards set by the Federal Office of Personnel Management.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Development Plan has the meaning set forth in Section 3.2.

  • Autism spectrum disorder means a neuro-developmental condition typically appearing in the first three years of life that significantly affects a person's ability to communicate, understand relationships and relate to others, and is frequently associated with unusual or stereotypical rituals or behaviours.

  • Development Consent means the consent granted to the Development Application for the Development and includes all modifications made under section 4.55 of the Act.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.